Ryan Fleming
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Monoclonal and Polyclonal Antibodies Research 17
- Oncology 16
- HER2/EGFR in Cancer Research 13
- Co-authors
- Changshou Gao (20 shared papers)Nazzareno Dimasi (20 shared papers)Herren Wu (18 shared papers)Binyam Bezabeh (12 shared papers)Steven Coats (3 shared papers)Shenlan Mao (6 shared papers)Leslie Wetzel (4 shared papers)R. James Christie (4 shared papers)
- Journals
- Cancer Research (5 papers)mAbs (4 papers)Molecular Pharmaceutics (2 papers)Applied Physics Letters (2 papers)Science Translational Medicine (2 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Ryan Fleming
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Radiology, Nuclear Medicine and Imaging 747
- Oncology 626
- Molecular Medicine 81
- Molecular Biology 606
- Immunology 163
Countries citing papers authored by Ryan Fleming
This map shows the geographic impact of Ryan Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Fleming more than expected).
Fields of papers citing papers by Ryan Fleming
This network shows the impact of papers produced by Ryan Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Fleming. The network helps show where Ryan Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 292 | |
| 2 | 2014 | 215 | |
| 3 | 2008 | 121 | |
| 4 | 2015 | 102 | |
| 5 | 2017 | 91 | |
| 6 | 2009 | 75 | |
| 7 | 2017 | 59 | |
| 8 | 2016 | 55 | |
| 9 | 2016 | 41 | |
| 10 | 2014 | 35 | |
| 11 | 2016 | 28 | |
| 12 | 2015 | 24 | |
| 13 | 2018 | 18 | |
| 14 | 2019 | 17 | |
| 15 | 2015 | 17 | |
| 16 | 2017 | 17 | |
| 17 | 2016 | 16 | |
| 18 | 2019 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 1979 | 9 |
About Ryan Fleming
Ryan Fleming is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Electrical and Electronic Engineering and Atomic and Molecular Physics, and Optics, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (17 papers), HER2/EGFR in Cancer Research (13 papers), Particle accelerators and beam dynamics (6 papers), Glycosylation and Glycoproteins Research (6 papers), Gyrotron and Vacuum Electronics Research (5 papers), Particle Accelerators and Free-Electron Lasers (4 papers), Diamond and Carbon-based Materials Research (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (747 citations), Oncology (626 citations), Molecular Medicine (81 citations), Molecular Biology (606 citations) and Immunology (163 citations). Ryan Fleming has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Changshou Gao, Nazzareno Dimasi, Herren Wu, Binyam Bezabeh, Steven Coats, Shenlan Mao, Leslie Wetzel, R. James Christie, Dorin Toader and Peter A. Kiener. Their work appears in journals such as Cancer Research, mAbs, Molecular Pharmaceutics, Applied Physics Letters and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.